Big Pharma markets left on a ‘patent cliff’-hanger
FT News Briefing
00:00
Navigating Pharmaceutical Challenges: Innovation Amid Patent Cliffs
This chapter explores how pharmaceutical companies are adapting to patent cliffs by acquiring biotech firms to foster innovation, highlighted by Merck's $10 billion acquisition of Verona Pharma. It also discusses the implications for the industry's future amid political risks and the challenges in developing highly profitable blockbuster drugs.
Transcript
Play full episode
